Thursday
February 27, 2025
4:05 PM ET
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Thursday
February 20, 2025
8:00 AM ET
Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025
Thursday
January 23, 2025
8:00 AM ET
Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma
Tuesday
November 12, 2024
4:05 PM ET
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Wednesday
November 6, 2024
8:30 AM ET
Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024